Challenges and climate of business environment and resources to support pediatric device development

Corey W Iqbal1, James Wall2, Michael R Harrison3

  • 1Department of Surgery, Children's Mercy Hospital, Kansas City, Missouri.

Insights

Pediatric orphan diseases are rare, leading to scarce resources for developing essential medical devices. This article addresses these unique challenges and proposes potential solutions for pediatric device innovation.

Area of Science:

  • Biomedical Engineering
  • Pediatric Medicine
  • Medical Device Development

Background:

  • Pediatric diseases are significantly less common than adult diseases, often classifying them as rare or orphan conditions.
  • The rarity of pediatric disorders results in limited research and development funding, particularly for medical devices.
  • This scarcity creates a substantial hurdle for creating innovative medical technologies tailored to children's needs.

Purpose of the Study:

  • To identify and delineate the specific challenges encountered in pediatric medical device development.
  • To explore the impact of orphan disease status on resource allocation for pediatric device innovation.
  • To propose actionable solutions and strategies to overcome these developmental obstacles.

Main Methods:

  • Literature review of existing pediatric device development challenges.
  • Analysis of resource allocation trends in rare pediatric disease research.
  • Case study examination of successful and unsuccessful pediatric device initiatives.

Main Results:

  • Key challenges include small patient populations, ethical considerations in pediatric trials, and regulatory complexities.
  • Limited market size for orphan pediatric devices deters commercial investment and innovation.
  • Existing funding mechanisms are often insufficient to support the full lifecycle of pediatric device development.

Conclusions:

  • Addressing the unique challenges of pediatric orphan diseases requires innovative funding models and collaborative efforts.
  • Streamlining regulatory pathways and incentivizing industry investment are crucial for advancing pediatric device technology.
  • Developing targeted medical devices for rare pediatric conditions is essential for improving health outcomes in this vulnerable population.

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Microenvironments01:22

Microenvironments

Microorganisms inhabit highly localized spaces known as microenvironments, which are defined by distinct physical and chemical characteristics. These include oxygen concentration, pH, temperature, light availability, and nutrient levels. The conditions within a microenvironment can differ markedly from those in the surrounding area and significantly influence microbial growth, metabolism, and community structure.Microenvironments often display sharp physicochemical gradients over small spatial...